key: cord-0760093-z4cgkf90 authors: Trifi, Ahlem; Ouhibi, Asma; Mahdi, Asma; Masseoud, Linda; Seghir, Eya; Meftah, Amal; Sellaouti, Salim; Abdennebi, Cyrine; Daly, Foued; Touil, Yosr; Abdellatif, Sami; Ben Lakhal, Salah title: Shunt in critically ill Covid-19 ARDS patients: Prevalence and impact on outcome (cross-sectional study) date: 2022-04-26 journal: J Crit Care DOI: 10.1016/j.jcrc.2022.154048 sha: 77b643e4d6d26a6726c0e35991f58861f71dc1bb doc_id: 760093 cord_uid: z4cgkf90 PURPOSE: To examine critical Covid-19-acute respiratory distress syndrome (C-ARDS) patients requiring mechanical ventilation (MV), using transthoracic echocardiography (TTE) coupled with bubble test (BT), in order to search a right/left shunt. METHODS: A Cross-sectional and comparative study comparing several parameters according to the presence or not of shunt. RESULTS: 75 patients were included. Twenty-three shunts (31%) were detected: patent foramen oval (PFO) type [n=11 (15%)] and trans-pulmonary transit of bubbles (TPBT) [n = 12 (16%)]. The shunt did not affect P/F ratio (P/F=77 vs 81, p=0.97), nor mortality. CONCLUSION: A right/left shunt was detected in a third of studied patients similarly between PFO and TPBT without significant impact on P/F ratio or outcome. Several autopsies studies reported that SARS-CoV-2-induces numerous vascular damages such thrombosis, apoptosis, edema, and anastomoses [1, 2] . In hypoxemic Covid-acute respiratory distress syndrome (C-ARDS) patients, transcranial agitated saline microbubble doppler studies, demonstrated a trans-pulmonary bubble transit (TPBT) [3] . TPBT may occur in perfused non-aerated lung areas secondary to pulmonary vessels dilatation and anastomoses. A shunt through the patent foramen ovale (PFO) may occur in the case of low compliance ARDS with pulmonary arterial hypertension. We aimed to explore critical C-ARDS patients under mechanical ventilation (MV); using trans-thoracic echocardiography (TTE) coupled with bubble test (BT) (TTE+BT) in order to look for PFO or TPBT and determine its impact on outcome. Design and population this single-center cross-sectional study enrolled consecutively patients from September 2020 to June 2021. Inclusion criteria were: 1-Age ≥ 18 years old, 2-patients with positive SARS-CoV-2 infection, 3-severe ARDS based on the Berlin definition and 4-under MV. Exclusion criterion was poor quality of ultrasound images or contrast test. The TTE+BT was performed within the first 24 h of MV by trained operators. Used ultrasonic device was of Aloka-ARIETTA V60 model from Hitachi Company. Referring to the technique used by Masi P and colleagues [4] , the right-to-left shunt was sought on the four-chamber view by injecting 9.5 ml of gelatine solution aerated with 0.5 ml of room air via two syringes connected to a three-way stopcock. Up to three successful contrast studies were performed on each patient. The Shunt was quantified according to the number of passed bubbles as follows: minor (<10), moderate (10−30) and large (>30) [4] [5] [6] . The data were analyzed using the SPSS Base 20 statistical software package. Continuous data were expressed as mean ± standard deviation (SD) or median [IQR 2575 ] and compared using the T student test or Mann-Whitney test as appropriate. Categorical variables, expressed as percentages, were compared using the chi-square test or Fisher exact test. Two-tailed p values inferior than 0.05 were considered significant. Results 161 patients were admitted to the ICU for CVID pneumonia among them, 83 were intubated and in whom the TTE+BT was carried out. Eight patients were excluded for inconclusive TTE/BT (n=5) and for intolerance of the supine positioning (n=3). Finally, 75 patients with a complete TTE+BT study were considered in the study. A shunt was detected in 23 cases (prevalence=31%). It was identified as TPBT in 12 cases (16%) and quantified as important (>30 bubbles) in 3 cases. PFO was revealed in 11 cases (15%) and 6/11were important. As showed in the jointed Table 1 , no major difference was observed for the baseline characteristics, para-clinical findings and therapeutic data. Patients in whom the shunt was detected have less hypertension (22% vs 56%, p= 0.01) and higher CRP (189 vs 142 mg/L, p = 0.024). All patients received, upon ICU admission, dexamethasone 6 mg daily for up to 10 days. Late steroids (2 weeks of unfavorable evolution), based on methylprednisolone 250 mg daily for 3 days followed by decreasing doses was prescribed in 7 patients without difference between groups. The presence of shunt did not extend MV duration or ICU-stay. Overall, the mortality was considerable regardless of the presence or not of the shunt. Our PFO prevalence (15%) was greater to that reported by Masi P and colleagues at 10% [4] ; but lower than that reported in non Covid-ARDS patients (19.2%) [5] . TPBT prevalence (16%) was lower than that of Masi P, et al. (20%) [4] and even lower than that in non Covid-ARDS patients (26%) [6] . The mortality rate we reported is comparatively quite high. Some factors can be considered as contributors to higher mortality: 1-the first and important reason is case mix in this cohort distinguished by its fragility of the underlying terrain (84% have at least one co morbidity), its illness severity (median SOFA = 6,5) and late timing of ICU admission (10 days on average). The case mix is, in fact, due to the local logistical strategy during this crisis that opted to devote our medical ICU entirely for very ill Covid patients, 2-very limited availability of therapeutics and rescue therapies. We estimated that the single-center design, the TTE used for bubble contrast, the selective of only patients under MV and just within the 24H could limit the generalization of our results. It is important to point out that the external validity of our study represents a major issue. In order to overcome that, we have planned a project of a study on a larger scale with the objective to determine the prevalence of a right/left shunt and its prognostic impact in all ICU patients. The design differs by the type of population to be included (ICU patients with SARS-CoV-2 pneumonia requiring or not invasive ventilation) and the participation of four Tunisian intensive care units. The study was approved by the local ethics committee of the hospital. The legal representatives of the included patients were informed by the study protocol and gave their consent. The investigation was conforming to the ethical norms of Helsinki declaration and its subsequent revisions. The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Pulmonary Angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19 Pulmonary vascular dilatation detected by automated transcranial Doppler in COVID-19 pneumonia Is hypoxemia explained by intracardiac or intrapulmonary shunt in COVID-19-related acute respiratory distress syndrome? Ann Intensive Care Prevalence and prognosis of shunting across patent foramen ovale during acute respiratory distress syndrome Echocardiographic detection of transpulmonary bubble transit during acute respiratory distress syndrome Not applicable.